Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$334M |
| 2 |
Marathon Petroleum
MPC
|
+$283M |
| 3 |
CVS Health
CVS
|
+$227M |
| 4 |
ConocoPhillips
COP
|
+$172M |
| 5 |
Linde
LIN
|
+$128M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$740M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$612M |
| 3 |
ANDV
Andeavor
ANDV
|
+$447M |
| 4 |
Cisco
CSCO
|
+$307M |
| 5 |
CA
CA, Inc.
CA
|
+$252M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.86% |
| 2 | Industrials | 13.02% |
| 3 | Technology | 12.73% |
| 4 | Healthcare | 10.57% |
| 5 | Consumer Discretionary | 10.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Lennar Class B
LEN.B
$19.4B
| $5.87M | ﹤0.01% |
197,188
-1,586
| -0.8% | -$52.1K |
|
2552
Clarus
CLAR
$123M
| $5.86M | ﹤0.01% |
581,406
+17,385
| +3% | +$182K |
|
2553
Genie Energy
GNE
$367M
| $5.86M | ﹤0.01% |
971,123
+14,897
| +2% | +$93.5K |
|
|
CBIO
2554
Crescent Biopharma
CBIO
$537M
| $5.85M | ﹤0.01% |
6,174
+2,286
| +59% | +$2.75M |
|
2555
Resideo Technologies
REZI
$5.19B
| $5.84M | ﹤0.01% |
+284,451
| New | +$6.07M |
|
|
HIL
2556
DELISTED
Hill International, Inc. Common Stock
HIL
| $5.82M | ﹤0.01% |
+1,888,624
| New | +$6.02M |
|
|
RNWK
2557
DELISTED
RealNetworks Inc
RNWK
| $5.79M | ﹤0.01% |
2,506,551
-26,595
| -1% | -$61.8K |
|
2558
Tower Semiconductor
TSEM
$24.8B
| $5.78M | ﹤0.01% |
392,330
+1,973
| +0.5% | +$32.9K |
|
|
IBA
2559
DELISTED
Industrias Bachoco SAB De C.V.
IBA
| $5.78M | ﹤0.01% |
146,229
-12,136
| -8% | -$539K |
|
|
SIFI
2560
DELISTED
SI Financial Group, Inc. NEW MD
SIFI
| $5.78M | ﹤0.01% |
454,225
+23,582
| +5% | +$319K |
|
|
FBMS
2561
DELISTED
The First Bancshares, Inc.
FBMS
| $5.78M | ﹤0.01% |
190,904
+12,618
| +7% | +$441K |
|
2562
Natural Alternatives International
NAII
$14.4M
| $5.77M | ﹤0.01% |
587,035
+34
| +0% | +$327 |
|
2563
STMicroelectronics
STM
$46.7B
| $5.76M | ﹤0.01% |
414,721
-724
| -0.2% | -$10.8K |
|
|
ARC
2564
DELISTED
ARC Document Solutions, Inc.
ARC
| $5.73M | ﹤0.01% |
2,795,818
+96,021
| +4% | +$234K |
|
|
PRCP
2565
DELISTED
Perceptron Inc
PRCP
| $5.72M | ﹤0.01% |
709,650
+194
| +0% | +$1.58K |
|
2566
Amtech Systems
ASYS
$268M
| $5.71M | ﹤0.01% |
1,261,386
+10,562
| +0.8% | +$51.6K |
|
|
FRBK
2567
DELISTED
Republic First Bancorp Inc
FRBK
| $5.69M | ﹤0.01% |
953,395
+145,523
| +18% | +$984K |
|
|
ENZ
2568
DELISTED
Enzo Biochem, Inc.
ENZ
| $5.64M | ﹤0.01% |
2,030,043
-12,558
| -0.6% | -$41.1K |
|
|
CBAY
2569
DELISTED
Cymabay Therapeutics
CBAY
| $5.64M | ﹤0.01% |
716,974
+370,985
| +107% | +$3.53M |
|
|
CLVS
2570
DELISTED
Clovis Oncology, Inc.
CLVS
| $5.64M | ﹤0.01% |
+314,083
| New | +$6.42M |
|
|
HWCC
2571
DELISTED
Houston Wire & Cable Company
HWCC
| $5.59M | ﹤0.01% |
1,104,048
+18,728
| +2% | +$120K |
|
|
OLP
2572
One Liberty Properties
OLP
$530M
| $5.57M | ﹤0.01% |
229,997
+5,367
| +2% | +$139K |
|
|
ADVM
2573
DELISTED
Adverum Biotechnologies
ADVM
| $5.57M | ﹤0.01% |
176,825
+12,652
| +8% | +$515K |
|
2574
Cumberland Pharmaceuticals
CPIX
$100M
| $5.55M | ﹤0.01% |
880,248
+1,900
| +0.2% | +$11.4K |
|
2575
Surgery Partners
SGRY
$2.01B
| $5.53M | ﹤0.01% |
565,283
-1,573
| -0.3% | -$21.1K |
|
Similar funds
Dimensional Fund Advisors's Q4 2018 Portfolio in Review
As of Q4 2018, Dimensional Fund Advisors held 3,519 positions worth $221B, down 16% from $263B the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.
Trading was light in Q4 2018: portfolio turnover was 4.6%. Dimensional Fund Advisors opened 94 new positions and exited 67, leaving the 3,519-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Industrials and Technology.
- Dimensional Fund Advisors's largest Q4 2018 buy was Linde: 812,164 shares worth $127M.
- Dimensional Fund Advisors added most to Cigna in Q4 2018, an estimated $334M increase.
- Dimensional Fund Advisors's biggest Q4 2018 reduction was Cisco, cutting an estimated $307M.
- Dimensional Fund Advisors fully exited Aetna Inc in Q4 2018, selling an estimated $740M.
- Dimensional Fund Advisors's ten largest holdings make up 9.7% of its $221B portfolio in Q4 2018.
- Dimensional Fund Advisors opened 94 new positions and closed 67 in Q4 2018.
- Dimensional Fund Advisors's portfolio value fell 16% quarter-over-quarter to $221B.
Based on Dimensional Fund Advisors's 13F filing for Q4 2018, filed 13 Feb 2019.